Findings

What do systematic reviews say?

10 questions · 10 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 10%GRADE not reported 0 · 0%Very low 1 · 10%Low 5 · 50%Moderate 2 · 20%High 1 · 10%

Combined OCP vs placebo or no treatment

Pain score ( · women with primary dysmenorrhoea

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 588 participants
High

Combined OCP vs placebo or no treatment

Pain improvement (assessed as improvement from 1 major category to next) · women with primary dysmenorrhoea

Combined OCP may leads to higher pain improvement (assessed as improvement from 1 major category to… compared with placebo or no treatment (low certainty).

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
RR 1.65 [1.29, 2.1]
6 studies · 717 participants
Low

Combined OCP vs placebo or no treatment

Adverse events · women with primary dysmenorrhoea

Combined OCP probably leads to higher adverse events compared with placebo or no treatment (moderate certainty).

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
RR 1.31 [1.2, 1.43]
7 studies · 1025 participants
Moderate

Combined OCP vs placebo or no treatment

Requirement for additional medication · women with primary dysmenorrhoea

Combined OCP may leads to lower requirement for additional medication compared with placebo or no treatment (low certainty).

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
RR 0.63 [0.4, 0.98]
2 studies · 163 participants
Low

Combined OCP vs placebo or no treatment

Time off school or work · women with primary dysmenorrhoea

Combined OCP may leads to lower absence from work or school compared with placebo or no treatment (low certainty).

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
RR 0.63 [0.41, 0.97]
2 studies · 148 participants
Low

Combined low‐dose OCP vs another combined low‐dose OCP

Adverse events for continuous vs standard regimen OCP · women with primary dysmenorrhoea

Combined low‐dose OCP may leads to higher adverse events for continuous vs standard regimen OCP compared with another combined low‐dose OCP (low certainty).

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
RR 1.11 [1.01, 1.22]
3 studies · 602 participants
Low

Combined low‐dose OCP vs another combined low‐dose OCP

Time off school or work · women with primary dysmenorrhoea

It is very uncertain whether combined low‐dose OCP changes absence from work or school compared with another combined low‐dose OCP (very low certainty).

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
RR 1.12 [0.64, 1.99]
1 study · 445 participants
Very low

Combined low‐dose OCP vs another combined low‐dose OCP

Pain score ( · women with primary dysmenorrhoea

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 106 participants
Low

Combined low‐dose OCP vs another combined low‐dose OCP

Pain improvement · women with primary dysmenorrhoea

Combined low‐dose OCP showed no clear difference in pain improvement compared with another combined low‐dose OCP (moderate certainty).

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
RR 1.06 [0.65, 1.74]
1 study · 326 participants
Moderate

Combined low‐dose OCP vs another combined low‐dose OCP

Requirement for additional medication · women with primary dysmenorrhoea

The review found no eligible studies for this question.

1 finding from 1 review

Combined oral contraceptive pill for primary dysmenorrhoea 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found